Skip to main content
. 2014 Feb 11;2:e256. doi: 10.7717/peerj.256

Table 2. Study descriptors.

Study Author(s) Aim of the study Study design Study measures Demographic factors Medical factors Time of measurement
1 Harrington, McGurk & Llewellyn (2008) (1) to determine the extent to which patient treated for HNC experience positive consequences of their illness, (2) to identify factors associated with benefit finding among this patient group Cross-sectional postal survey Benefit finding scale (BFS), Hospital Anxiety and Distress Scale (HADS), Life Orientation Test-Revised (LOT-R), Brief COPE Age, Gender, Ethnicity, Education, Employment, Marital status Type of treatment, time since last treatment, diagnosis of further illness since treatment, site, type of cancer and stage of cancer 0–6mths = 1, 6–12mths = 3, 13–24mths = 7, 25–47mths = 20, 48–72mths = 19, 73–121mths = 26
2 Llewellyn et al. (2011) (1) to determine the extent to which patient treated for HNC experience positive consequences of their illness, (2) to establish the relationship between BF, other patient-reported outcomes and predictive factors such as coping strategy and level of optimism Repeated measures prospective study using self-completion questionnaires Benefit finding scale (BFS), Hospital Anxiety and Distress Scale (HADS), Life Orientation Test (LOT-R), Brief COPE, Medical Outcomes Short Form 12 (SF-12), Two-item measure derived from The European Organization for Research and Treatment (EORTC) of Cancer Quality of Life Questionnaire (QLQ-C30) Age, Gender, Ethnicity, Education, Employment, Marital status Type of treatment, site and stage of cancer T1 = Between diagnosis and start of treatment, T2 = 6 months after completion of treatment
3 Ho et al. (2011) Investigate if PTG occurs in oral cancer patients and if hope and optimism shows significant positive correlation with PTG Cross-sectional postal survey Chinese Posttraumatic Growth Inventory (PTGI), Hope scale (HS), Life Orientation Test - Revised (LOT-R) Age, Gender, Religion, Education level, income Time since diagnosis, stage of disease, and treatment type Mean time was 3.6yrs (SD 0.34)
4 S Harding & T Moss, (2013a, unpublished data) Investigate the relationship between BF, demographical, biomedical and HRQoL following the treatment for HNC Cross-sectional postal survey Silver Lining Questionnaire (SLQ), University of Washington Head and Neck Caner Quality of Life (UoW), Medical Outcomes Short Form 12 (SF-12) Age at diagnosis, Age at time of completing questionnaire, Gender, Ethnicity, Index of Multiple Deprivation, Occupation, Family Status Tumour site, Stage of disease, Location of tumour, Treatment Mean time from completing treatment to completing questionnaires 27.30mths (Range 3–76; SD 21.8)
5 S Harding & T Moss, (2013b, unpublished data) Investigate the longitudinal relationship between BF, demographical, biomedical and HRQoL following the treatment for HNC Repeated measures prospective cross-sectional study using self-completion questionnaires Silver Lining Questionnaire (SLQ), University of Washington Head and Neck Caner Quality of Life (UoW), Medical Outcomes Short Form 12 (SF-12) Age at diagnosis, Age at time of completing questionnaire, Gender, Ethnicity, Index of Multiple Deprivation, Occupation, Family Status Tumour site, Stage of disease, Location of tumour, Treatment